Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutant p53 product in patients with stage III cervical cancer.

Anticancer research - 1 Jan 2000

Gitsch G, Kainz C, Joura E, Breitenecker G

Abstract excerpt

Mutations in the p53 gene stimulate cell division. In our study we assessed the prognostic value of mutant p53 overexpression in cervical cancer stage FIGO III detected by immunohistochemistry. In 43 tissue specimens were detected p53 overexpression in 20 cases. Mean survival time was 36.4 (SE +/- 7.66) months in the p53 protein positive group. The group without p53 overexpression showed a mean survival time of...

Topics

Female
Gene Expression
Genes, p53
Humans
Immunohistochemistry
Middle Aged
Mutation
Neoplasm Staging
Open Reading Frames
Prognosis
Survival Analysis
Tumor Suppressor Protein p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Uterine Cervical Neoplasms

Source

Identifiers

PMID: 1295470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-1295470-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutant p53 product in patients with stage III cervical cancer.PMID 1295470Read ↗

Mutant p53 in patients with invasive cervical cancer stages IB to IIB.Semantic proximity Read ↗

p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis.Semantic proximity Read ↗

p53 overexpression as a prognostic indicator in endometrial carcinoma.Semantic proximity Read ↗

Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.Semantic proximity Read ↗

Immunohistochemical Evaluation of the Role of p53 Mutation in Cervical Cancer: Ser-20 p53-Mutant Correlates with Better Prognosis.Semantic proximity Read ↗

p53 as a prognostic factor for stage III serous adenocarcinoma of the ovary.Semantic proximity Read ↗

p53 oncoprotein as a prognostic indicator in patients with breast cancer.Semantic proximity Read ↗

Mutant p53 protein in the serum of patients with cervical carcinoma: correlation with the level of serum epidermal growth factor receptor and prognostic significance.Semantic proximity Read ↗

Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.Semantic proximity Read ↗

Analysis of the p53 gene in human uterine carcinoma cell lines.Semantic proximity Read ↗

The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines.Semantic proximity Read ↗

Evaluation of p53 protein as a prognostic factor for oral cancer surgery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.